Correlation Between PTC Therapeutics and Avidity Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PTC Therapeutics and Avidity Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PTC Therapeutics and Avidity Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PTC Therapeutics and Avidity Biosciences, you can compare the effects of market volatilities on PTC Therapeutics and Avidity Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PTC Therapeutics with a short position of Avidity Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of PTC Therapeutics and Avidity Biosciences.

Diversification Opportunities for PTC Therapeutics and Avidity Biosciences

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between PTC and Avidity is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding PTC Therapeutics and Avidity Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avidity Biosciences and PTC Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PTC Therapeutics are associated (or correlated) with Avidity Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avidity Biosciences has no effect on the direction of PTC Therapeutics i.e., PTC Therapeutics and Avidity Biosciences go up and down completely randomly.

Pair Corralation between PTC Therapeutics and Avidity Biosciences

Given the investment horizon of 90 days PTC Therapeutics is expected to generate 1.21 times less return on investment than Avidity Biosciences. But when comparing it to its historical volatility, PTC Therapeutics is 1.15 times less risky than Avidity Biosciences. It trades about 0.21 of its potential returns per unit of risk. Avidity Biosciences is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  3,079  in Avidity Biosciences on November 8, 2024 and sell it today you would earn a total of  432.00  from holding Avidity Biosciences or generate 14.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

PTC Therapeutics  vs.  Avidity Biosciences

 Performance 
       Timeline  
PTC Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in PTC Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental indicators, PTC Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Avidity Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Avidity Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

PTC Therapeutics and Avidity Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PTC Therapeutics and Avidity Biosciences

The main advantage of trading using opposite PTC Therapeutics and Avidity Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PTC Therapeutics position performs unexpectedly, Avidity Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avidity Biosciences will offset losses from the drop in Avidity Biosciences' long position.
The idea behind PTC Therapeutics and Avidity Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account